BioMarin Pharmaceuticals
BMRN
BMRN
495 hedge funds and large institutions have $13.6B invested in BioMarin Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 189 increasing their positions, 182 reducing their positions, and 93 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
27% less funds holding in top 10
Funds holding in top 10: 11 → 8 (-3)
32% less first-time investments, than exits
New positions opened: 63 | Existing positions closed: 93
39% less capital invested
Capital invested by funds: $22.3B → $13.6B (-$8.73B)
Holders
495
Holding in Top 10
8
Calls
$189M
Puts
$158M
Top Buyers
| 1 | +$312M | |
| 2 | +$275M | |
| 3 | +$169M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$71.8M |
| 5 |
DLPIC
Davide Leone & Partners Investment Company
London,
United Kingdom
|
+$68.8M |
Top Sellers
| 1 | -$528M | |
| 2 | -$277M | |
| 3 | -$119M | |
| 4 |
BlackRock
New York
|
-$101M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$100M |